Company
Avalo Therapeutics Inc AVTX
Tracked across 1 disclosed holder on Protégé.
Held by these investors
| Investor | % of portfolio | Value |
|---|---|---|
| Farallon Capital Management | 0.3% | $46.2M |
Company
Tracked across 1 disclosed holder on Protégé.
| Investor | % of portfolio | Value |
|---|---|---|
| Farallon Capital Management | 0.3% | $46.2M |